Faculty profile

Christel Renoux

ResearcherClinical EpidemiologyMcGill University

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a McGill University directory, so their courses may be missing. Find their university profile.

Christel Renoux

Researcher

Clinical Epidemiology

Health Sciences

McGill University

Montreal, Quebec, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
42 publications in the last five years, latest in 2026.
Senior (last) author on 23 recent papers, a sign of leading a research group.
Principal investigator on 10 research grants (10 CIHR), most recently in 2026.
Supervised 2 trainees who won CIHR awards, most recently in 2022.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

108

Publications

164

Citations

h-index

Collaborators

Grants

Publications by year

Counts cover the works listed on the university profile; citation counts come from Dimensions.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Pharmacoepidemiology Cohort Cohort Study Copd Electronic Medical Records Drug Safety Sex Cardiovascular Disease

Latest papers

Comparative effectiveness and safety of oral anticoagulants in patients with atrial fibrillation using antiarrhythmic drugs: An international cohort study.
British journal of clinical pharmacology · 2026
Effectiveness of Beta-Blockers in COPD and Cardiovascular Disease: Real-World Effects on Mortality.
Chest · 2026
Direct Oral Anticoagulants, COX-2-Selective NSAIDs, and Gastrointestinal Bleeding in Atrial Fibrillation.
JAMA network open · 2026

All 108 publications

Latest funding

Sex differences in the risk of severe exacerbations associated with sedative drugs alone or in combination in patients with chronic obstructive pulmonary disease
CIHR · 2026 · Nominated PI
$298,350
Course and predictors of patient-reported outcomes from systemic sclerosis onset: A Scleroderma Patient-centered Intervention Network Cohort longitudinal study and individual participant data meta-analysis
CIHR · 2025 · Co-investigator
$967,726
Assessing the protective effect of dutasteride on Parkinson's disease: a real-world study following preclinical assessment
CIHR · 2025 · Co-investigator
$328,952

All 32 grants and awards

108 publications.

Comparative effectiveness and safety of oral anticoagulants in patients with atrial fibrillation using antiarrhythmic drugs: An international cohort study.

Meinert FM, Dimakos J, Cui Y, Filion KB, Renoux C, Douros A

British journal of clinical pharmacology2026

DOI: 10.1002/bcp.70391 PMID: 41316911

Effectiveness of Beta-Blockers in COPD and Cardiovascular Disease: Real-World Effects on Mortality.

Suissa S, Dell'Aniello S, Renoux C, Ernst P

Chest2026

DOI: 10.1016/j.chest.2026.06.074 PMID: 42580516

Direct Oral Anticoagulants, COX-2-Selective NSAIDs, and Gastrointestinal Bleeding in Atrial Fibrillation.

Meinert FM, Dimakos J, Cui Y, Filion KB, Renoux C, Douros A

JAMA network open2026

DOI: 10.1001/jamanetworkopen.2026.13941 PMID: 42189542

Incretin-Based Drugs and the Risk of Dementia Among Patients with Type 2 Diabetes.

Wang YH, Johnson K, Beradid S, Yin H, Yu OHY, Suissa S, Azoulay L, Renoux C

Drug safety2026Senior author

DOI: 10.1007/s40264-025-01623-9 PMID: 41123870

Trends in first-line monotherapy and combination therapy for hypertension in UK primary care.

Johnson K, Beradid S, Brophy JM, Platt RW, Renoux C

British journal of clinical pharmacology2026Senior author

DOI: 10.1002/bcp.70271 PMID: 40944617

Effectiveness and safety of rivaroxaban vs. apixaban in patients with atrial fibrillation and peripheral artery disease.

Dari L, Beradid S, Constans J, Pariente A, Renoux C

European heart journal. Cardiovascular pharmacotherapy2025Senior author

DOI: 10.1093/ehjcvp/pvaf063 PMID: 40884391

Risk of Severe Exacerbation Associated with Gabapentinoid Use in Patients with Chronic Obstructive Pulmonary Disease: A Population-Based Cohort Study.

Olaoye O, Dell'Aniello S, Ernst P, Suissa S, Renoux C

COPD2025Senior author

DOI: 10.1080/15412555.2025.2534002 PMID: 40699157

Concomitant use of direct oral anticoagulants and interacting antiarrhythmic drugs and the risk of stroke and bleeding among patients with non-valvular atrial fibrillation: a multinational cohort study.

Meinert FM, Dimakos J, Cui Y, Filion KB, Renoux C, Douros A

BMC medicine2025

DOI: 10.1186/s12916-025-04464-6 PMID: 41152878

Letter Reply to: Reassessing Gabapentinoids in Chronic Obstructive Pulmonary Disease: Emerging Respiratory Safety Concerns.

Olaoye O, Dell'Aniello S, Ernst P, Suissa S, Renoux C

COPD2025Senior author

DOI: 10.1080/15412555.2025.2547722 PMID: 40859761

Emulating randomized trials: treading carefully and pushing the limits.

Renoux C, Suissa S

American journal of epidemiology2025First author

DOI: 10.1093/aje/kwaf023 PMID: 40037631

Write to this professor

A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.

Applying for

Paper to mentionMention their CIHR grant from 2026

Subject: Prospective PhD student: Pharmacoepidemiology Dear Professor Renoux, My name is [your name], and I am a [your current degree or role] at [your institution]. I am applying for a PhD position starting in [term and year]. I read your paper "Comparative effectiveness and safety of oral anticoagulants in patients with atrial fibrillation using antiarrhythmic drugs: An international cohort study." (2026), and it connects closely to my own work on [your research topic]. [One or two sentences on what you did and what you learned.] I also saw your CIHR-funded project "Sex differences in the risk of severe exacerbations associated with sedative drugs alone or in combination in patients with chronic obstructive pulmonary disease" (2026), and I would be glad to contribute to work in that direction. Are you accepting new PhD students for [term and year]? I have attached my CV and transcripts, and I would be glad to talk at a time that suits you. Thank you for your time. Kind regards, [your name]

Something wrong or missing on this profile? Suggest a correction

Christel Renoux

Research

Latest papers

Latest funding

Comparative effectiveness and safety of oral anticoagulants in patients with atrial fibrillation using antiarrhythmic drugs: An international cohort study.

Effectiveness of Beta-Blockers in COPD and Cardiovascular Disease: Real-World Effects on Mortality.

Direct Oral Anticoagulants, COX-2-Selective NSAIDs, and Gastrointestinal Bleeding in Atrial Fibrillation.

Incretin-Based Drugs and the Risk of Dementia Among Patients with Type 2 Diabetes.

Trends in first-line monotherapy and combination therapy for hypertension in UK primary care.

Effectiveness and safety of rivaroxaban vs. apixaban in patients with atrial fibrillation and peripheral artery disease.

Risk of Severe Exacerbation Associated with Gabapentinoid Use in Patients with Chronic Obstructive Pulmonary Disease: A Population-Based Cohort Study.

Concomitant use of direct oral anticoagulants and interacting antiarrhythmic drugs and the risk of stroke and bleeding among patients with non-valvular atrial fibrillation: a multinational cohort study.

Letter Reply to: Reassessing Gabapentinoids in Chronic Obstructive Pulmonary Disease: Emerging Respiratory Safety Concerns.

Emulating randomized trials: treading carefully and pushing the limits.

Frequent collaborators

Samy Suissa

Laurent Azoulay

Laurent Azoulay

Antonios Douros

Madeleine Durand

Janie Coulombe

Soham Rej

Madeleine Durand

Paul Brassard

J Michael Paterson

Marie Hudson

Tibor Schuster

Giada Sebastiani

Paul Khairy

Jean-Eric Tarride

Anne Marie Holbrook

Charity Evans

Sherif Eltonsy

Emilie Trinh

Jacqueline Quail

Denis Talbot

Oriana Yu

Alain Bitton

David Barber

Olli Saarela

Haim Abenhaim

Sasha Bernatsky

Serge Gauthier

Connie Marras

Lucie Blais

Vicky Tagalakis